The European Medicines Agency (EMA) has announced its approval of two new biosimilar medications, Afqlir and Opuviz, to treat age-related macular degeneration (ARMD). The active ingredient of both ...
One of the first studies of its kind finds that inadvertent exposure during early pregnancy to glucagon-like peptide 1 receptor agonists (GLP1-RAs) is not associated with major birth defects or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback